Mainz Biomed N.V. Board of Directors

Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. It has a collaboration agreement with Thermo Fisher Scientific Inc. for the development of colorectal cancer screening product. The company was founded in 2008 and is based in Mainz, Germany.

Mr. Guido Baechler

Mr. Guido Baechler

CEO & Executive Director

Dr. Moritz Eidens Ph.D.

Dr. Moritz Eidens Ph.D.

Chief Science Officer & Executive Director

Stefan Erlach

Stefan Erlach

Head of Human Resources

Dr. Frank Krieg-Schneider

Dr. Frank Krieg-Schneider

Chief Technology Officer

Mr. Philipp Freese

Mr. Philipp Freese

Chief Business Officer

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.